Comparison Overview
ZOLL TherOx

ZOLL TherOx
N/A
Last Update: 28/01/2026
TherOx is a part of ZOLL Medical Corporation. Based in San Jose, California, TherOx is focused on improving the treatment of heart attacks (acute myocardial infarction, or AMI). The company is commercializing SuperSaturated Oxygen (SSO2) Therapy for the sizeable AMI pat...

Zimmer Biomet
345 East Main Street, P.O. Box 708, Warsaw, Indiana, US, 46580
Last Update: 01/04/2026
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and s...
Compliance Ranges Comparison

ZOLL TherOx







Zimmer Biomet






Benchmark & Cyber Underwriting Signals
Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)
No incidents recorded for ZOLL TherOx in 2026.
Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)
No incidents recorded for Zimmer Biomet in 2026.
Incident History - ZOLL TherOx (X = Date, Y = Severity)
ZOLL TherOx cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Zimmer Biomet (X = Date, Y = Severity)
Zimmer Biomet cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

ZOLL TherOx

Zimmer Biomet
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.